BABirthe Aufenberg

Birthe Aufenberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Birthe Aufenberg has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of an Intersectoral Telemedicine Intervention on Hospitalization in Nursing Home Patients: Specification Curve Analysis of a Stepped Wedge Cluster Randomized Trial

    by John Grosser, Sophie Pauge, Birthe Aufenberg, Wolfgang Greiner, Miriam Hertwig, Jenny Unterkofler, David Brücken, Christian Hübel, Optimal@Nrw Research Group, Jörg Christian Brokmann

    Background: The use of emergency medical services in Germany has significantly increased, particularly for nonemergency cases. This issue becomes especially relevant for nursing homes, where staff is confronted with resource shortages and organizational challenges, making emergency medical services involvement a common course of action. This leads to potentially avoidable hospitalizations for nursing home residents and exposes them to severe health risks, such as nosocomial infections. To address this, we developed the Optimal@NRW project, implementing an innovative intersectoral telemedicine intervention that includes an early warning system and mobile nonphysician medical assistants in order to enable outpatient treatment in acute medical cases for nursing home residents. We hypothesize that hospitalizations could be significantly reduced, as patients could be treated on-site in the absence of a life-threatening emergency. Objective: This study aims to determine the effect of an intersectoral telemedicine-based intervention for acute care situations on hospitalization among residents in nursing homes. Methods: We conducted a prospective multicenter cluster-randomized stepped wedge trial from May 2021 to April 2023 across 24 nursing homes in western Germany. Nursing homes were randomly assigned to one of four sequences and followed over eight 3-month periods. All sequences crossed stepwise from the control to the intervention phase. We collected primary data in an electronic patient record and claims data from statutory health insurance funds. In a specification curve analysis, we evaluated the intervention effect using multiple mixed-effects regression model specifications with varying modeling approaches, datasets, dependent and independent variables, and operationalizations. Results: The number of participants ranged from 158 to 285 nursing home residents per sequence and period, totaling 1151 participants in the control phase and 1271 participants in the intervention phase. A total of 1260 regression models were analyzed. Approximately two-thirds of all models exhibited a negative (ie, protective) intervention effect. However, no models exhibited a statistically significant (ie, P <.05) intervention effect. The distribution of effect direction and size differed by modeling approach, choice of outcome, and dataset used. Conclusions: Our results do not support the hypothesis of a significant reduction of hospitalizations among nursing home residents. The effectiveness of the intervention may have been compromised by external factors such as a flood disaster in the study region and the COVID-19 pandemic, which introduced unforeseen challenges. Future studies should prioritize targeted outcomes (potentially avoidable hospitalizations) that align with the specific intervention mechanism, while also allowing for extended implementation periods to ensure that interventions reach their full potential.

  • Open Access

    How do financial considerations influence medical decision-making? A qualitative-empirical study in German cancer medicine

    by Julia Felicitas Leni König, Birthe Aufenberg, Gereon Brei, Sophia Reitmayer, Sabine Sommerlatte, Wolfgang Greiner, Jan Schildmann, Eva Caroline Winkler, Katja Mehlis

    Introduction: The question of how financial considerations influence medical decision-making is coming to a head in cancer medicine, as cancer medicine is getting more expensive and extensive. As the debate continues, empirical data on specific decision-making situations that are influenced by financial consideration and on the characterisation of financial influence in cancer medicine remain scarce. Methods: We conducted a qualitative semistructured interview study with physicians who had experience in controlling and budgeting in different settings of cancer care in Germany. Qualitative content analysis was performed to identify specific decision-making situations in cancer medicine influenced by financial considerations and to characterise the financial influence. Results: n=16 interviews were conducted. We identified 21 medical decision-making situations influenced by financial considerations specific to cancer medicine, which were characterised into four subcategories of financial influence derived from the data: (1) no reimbursement, (2) reimbursement that does not completely cover costs, (3) reimbursement that exceeds the costs and (4) costs covered for treatments with questionable cost-effectiveness. These results imply that medical decisions in cancer medicine could be influenced by financial considerations. Conclusions: The findings support the hypothesis that medical decision-making in cancer medicine can be influenced by financial considerations. They provide specific examples and a characterisation of the influence as starting points for further quantitative studies on the extent of the financial influence and on the possible effect on high-risk patient groups. Further, they underline the need for ethical analysis regarding the implications for quality of care.